4//SEC Filing
SCANGOS GEORGE A 4
Accession 0001628280-24-026219
CIK 0001706431other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 12:17 PM ET
Size
10.1 KB
Accession
0001628280-24-026219
Insider Transaction Report
Form 4
SCANGOS GEORGE A
Director
Transactions
- Award
Common Stock
2024-05-30+8,000→ 120,989 total - Award
Stock Option (Right to Buy)
2024-05-30+16,000→ 16,000 totalExercise: $10.39From: 2025-05-30Exp: 2034-05-29→ Common Stock (16,000 underlying)
Holdings
- 1,750,000(indirect: See footnote)
Common Stock
- 1,750,000(indirect: See footnote)
Common Stock
- 33,629(indirect: See footnote)
Common Stock
- 179,930(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]The shares are held in the name of the George A Scangos 2023 Annuity Trust, of which the reporting person and his spouse are Trustees.
- [F2]The shares are held in the name of Leslie Wilson 2023 Annuity Trust, of which the reporting person and his spouse are Trustees.
- [F3]The shares are held in the name of George A. Scangos, as Trustee of the Scangos-Wilson Family Trust dated May 12, 2011.
- [F4]The shares are held in the name of the Scangos 2018 Grandchildren's Trust, of which the reporting person and his spouse are Trustees.
Documents
Issuer
Vir Biotechnology, Inc.
CIK 0001706431
Entity typeother
Related Parties
1- filerCIK 0001202102
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 12:17 PM ET
- Size
- 10.1 KB